Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1983 1
2003 1
2004 1
2005 2
2007 5
2008 8
2009 5
2010 2
2011 2
2012 3
2013 6
2014 2
2015 1
2016 1
2017 4
2018 4
2019 4
2020 4
2021 6
2022 8
2023 8
2024 9
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Flexibility in zeolites: origin, limits, and evaluation.
Ghojavand S, Dib E, Mintova S. Ghojavand S, et al. Among authors: dib e. Chem Sci. 2023 Oct 23;14(44):12430-12446. doi: 10.1039/d3sc03934j. eCollection 2023 Nov 15. Chem Sci. 2023. PMID: 38020361 Free PMC article. Review.
Vital dyes for chromovitrectomy.
Rodrigues EB, Maia M, Meyer CH, Penha FM, Dib E, Farah ME. Rodrigues EB, et al. Among authors: dib e. Curr Opin Ophthalmol. 2007 May;18(3):179-87. doi: 10.1097/ICU.0b013e32811080b5. Curr Opin Ophthalmol. 2007. PMID: 17435423 Review.
Toxicological considerations for intravitreal drugs.
Penha FM, Rodrigues EB, Furlani BA, Dib E, Melo GB, Farah ME. Penha FM, et al. Among authors: dib e. Expert Opin Drug Metab Toxicol. 2011 Aug;7(8):1021-34. doi: 10.1517/17425255.2011.585970. Epub 2011 Jun 1. Expert Opin Drug Metab Toxicol. 2011. PMID: 21627546 Review.
[Vital dyes in chromovitrectomy].
Dib E, Rodrigues EB, Maia M, Meyer CH, Penha FM, Furlani Bde A, Costa Ede P, Farah ME. Dib E, et al. Arq Bras Oftalmol. 2009 Nov-Dec;72(6):845-50. doi: 10.1590/s0004-27492009000600022. Arq Bras Oftalmol. 2009. PMID: 20098913 Free article. Review. Portuguese.
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Cannon TL, Rothe M, Mangat PK, Garrett-Mayer E, Chiu VK, Hwang J, Vijayvergia N, Alese OB, Dib EG, Duvivier HL, Klute KA, Sahai V, Ahn ER, Bedano P, Behl D, Sinclair S, Thota R, Urba WJ, Yang ES, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. Cannon TL, et al. Among authors: dib eg. J Clin Oncol. 2024 Sep 20;42(27):3228-3237. doi: 10.1200/JCO.23.02078. Epub 2024 May 15. J Clin Oncol. 2024. PMID: 38748939 Clinical Trial.
The use of vital dyes in ocular surgery.
Rodrigues EB, Costa EF, Penha FM, Melo GB, Bottós J, Dib E, Furlani B, Lima VC, Maia M, Meyer CH, Höfling-Lima AL, Farah ME. Rodrigues EB, et al. Among authors: dib e. Surv Ophthalmol. 2009 Sep-Oct;54(5):576-617. doi: 10.1016/j.survophthal.2009.04.011. Surv Ophthalmol. 2009. PMID: 19682624 Review.
Case reports and the fight against cancer.
Dib EG, Kidd MR, Saltman DC. Dib EG, et al. J Med Case Rep. 2008 Feb 6;2:39. doi: 10.1186/1752-1947-2-39. J Med Case Rep. 2008. PMID: 18254961 Free PMC article.
80 results